Weight Distribution Asymmetry in Relation to Speed During Gait in Children With Spastic Cerebral Palsy.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04636424 |
|
Recruitment Status :
Completed
First Posted : November 19, 2020
Last Update Posted : November 19, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background: Improving walking ability is one of the major concerns in therapeutic interventions for children with cerebral palsy.
Aim: determine the relation between the weight distributed on both lower limb and speed during walking.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Gait, Spastic | Other: assesment of gait | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 114 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Weight Distribution Asymmetry in Relation to Speed During Gait in Children With Spastic Cerebral Palsy. |
| Actual Study Start Date : | December 3, 2019 |
| Actual Primary Completion Date : | March 5, 2020 |
| Actual Study Completion Date : | November 1, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: spastic diplegic group
assessment of the speed and weight distribution during gait
|
Other: assesment of gait
speed and weight distribution during gait |
|
Experimental: hemiplegic group
assessment of the speed and weight distribution during gait
|
Other: assesment of gait
speed and weight distribution during gait |
- speed of gait [ Time Frame: 12 weaks ]the velocity of walking
- foot to foot distribution [ Time Frame: 12 weaks ]weight loaded on each lower limb during gait assessment
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 10 Years to 12 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
The selection criteria to the diplegic group were as follows:
- children diagnosed as spastic diplegia or hemiplegia;
- the ability to stand independently without support for not less than 30 seconds;
- the ability to walk independently; a classification of level II in the Gross Motor Function Classification System (GMFCS);
- and capability to understand simple verbal commands.
Exclusion criteria:
- Participants were excluded if they were treated for lower limbs orthopedic surgical or with botulinum toxin injection within the last 6 months
- or if they had fixed lower limb deformity.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04636424
| Egypt | |
| Faculty of Physical Therapy,Cairo University | |
| Cairo, Giza, Egypt, 02 | |
| Study Director: | Nahla Mohamed | Cairo University |
| Responsible Party: | Nahla Mohamed Ibrahim, Doctoral degree (lecturer), Cairo University |
| ClinicalTrials.gov Identifier: | NCT04636424 |
| Other Study ID Numbers: |
correlation study |
| First Posted: | November 19, 2020 Key Record Dates |
| Last Update Posted: | November 19, 2020 |
| Last Verified: | November 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | the results will be shared with other researchers as the paper published |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) |
| Time Frame: | after publication of the paper |
| Access Criteria: | through the journal of the published paper |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
assymetry-gait-speed-cerebral palsy |
|
Muscle Spasticity Cerebral Palsy Gait Disorders, Neurologic Brain Damage, Chronic Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Muscular Diseases Musculoskeletal Diseases Muscle Hypertonia Neuromuscular Manifestations Neurologic Manifestations |

